Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14564 | 695 | 30.8 | 70% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1620 | 6498 | PNEUMOCYSTIS CARINII//PNEUMOCYSTIS JIROVECII//PNEUMOCYSTIS CARINII PNEUMONIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ATOVAQUONE | Author keyword | 8 | 23% | 4% | 31 |
2 | TOXOPLASMIC ENCEPHALITIS | Author keyword | 7 | 36% | 2% | 15 |
3 | TOXOPLASMA ENCEPHALITIS | Author keyword | 5 | 47% | 1% | 8 |
4 | AEROSOLIZED PENTAMIDINE | Author keyword | 5 | 37% | 1% | 10 |
5 | PNEUMOCYSTIS CARINII PNEUMONIA | Author keyword | 4 | 11% | 5% | 35 |
6 | AEROSOL PENTAMIDINE | Author keyword | 2 | 67% | 0% | 2 |
7 | DISCONTINUATION OF PROPHYLAXIS | Author keyword | 2 | 67% | 0% | 2 |
8 | TOXOPLASMA SEROLOGY | Author keyword | 2 | 67% | 0% | 2 |
9 | ANTI TOXOPLASMA GONDII ACTIVITY | Author keyword | 1 | 50% | 0% | 2 |
10 | CRB TOXOPLASMA | Address | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AEROSOLIZED PENTAMIDINE | 27 | 26% | 13% | 90 |
2 | DAPSONE PYRIMETHAMINE | 21 | 57% | 4% | 25 |
3 | TOXOPLASMIC ENCEPHALITIS | 16 | 33% | 6% | 40 |
4 | NERVOUS SYSTEM TOXOPLASMOSIS | 15 | 47% | 3% | 24 |
5 | SECONDARY PROPHYLAXIS | 13 | 21% | 8% | 54 |
6 | HYDROXYNAPHTHOQUINONE 566C80 | 11 | 57% | 2% | 13 |
7 | WEEKLY DAPSONE PYRIMETHAMINE | 11 | 100% | 1% | 6 |
8 | CYST FORM | 9 | 64% | 1% | 9 |
9 | 566C80 | 9 | 27% | 4% | 28 |
10 | DOSE TRIMETHOPRIM SULFAMETHOXAZOLE | 9 | 83% | 1% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Guidelines for preventing opportunistic infections among HIV-infected persons - 2002 - Recommendations of the US Public Health Service and the Infectious Diseases Society of America | 2002 | 125 | 106 | 27% |
Meta-analysis of prevention and treatment of toxoplasmic encephalitis in HIV-infected patients | 2013 | 4 | 34 | 56% |
Discontinuation of Pneumocystis jirovecii Pneumonia Prophylaxis with CD4 Count <200 Cells/mu L and Virologic Suppression: A Systematic Review | 2011 | 6 | 33 | 61% |
Drug therapy: Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection. | 2000 | 130 | 75 | 27% |
Use of dapsone in the prevention and treatment of Pneumocystis carinii pneumonia: A review | 1998 | 49 | 50 | 46% |
Treatment regimens for patients with toxoplasmic encephalitis | 1996 | 30 | 55 | 71% |
TOXOPLASMOSIS IN HIV/AIDS: A LIVING LEGACY | 2009 | 17 | 119 | 32% |
Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings) | 2006 | 7 | 18 | 61% |
PROPHYLAXIS FOR OPPORTUNISTIC INFECTIONS IN PATIENTS WITH HIV-INFECTION | 1994 | 113 | 126 | 30% |
ATOVAQUONE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN OPPORTUNISTIC INFECTIONS | 1995 | 35 | 42 | 40% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CRB TOXOPLASMA | 1 | 100% | 0.3% | 2 |
2 | CLIN CRIT CARE MED | 1 | 40% | 0.3% | 2 |
3 | CNR TOXOPLASMOSE | 1 | 33% | 0.3% | 2 |
4 | ABT INFEKTIONSKRANKHEITEN SPITALHYG | 1 | 50% | 0.1% | 1 |
5 | AIDS AIDS CLIN TRIALS GRP | 1 | 50% | 0.1% | 1 |
6 | BIOL OURCE TOXOPLASMA | 1 | 50% | 0.1% | 1 |
7 | COMPREHENS INFECT DIS ULM | 1 | 50% | 0.1% | 1 |
8 | DIRECC INVEST OPERAT | 1 | 50% | 0.1% | 1 |
9 | GRP FISIOL MOL | 1 | 50% | 0.1% | 1 |
10 | HOSP PREVENT MED INFECT DIS | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000205537 | CONGENITAL TOXOPLASMOSIS//TOXOPLASMOSIS//OCULAR TOXOPLASMOSIS |
2 | 0.0000188916 | PNEUMOCYSTIS JIROVECII//PNEUMOCYSTIS CARINII//PNEUMOCYSTIS PNEUMONIA |
3 | 0.0000120054 | APICOPLAST//41H QUINOLONES//ORGANELLAR TARGETING |
4 | 0.0000115190 | HPPK//DIHYDROPTEROATE SYNTHASE//PYROPHOSPHOKINASE |
5 | 0.0000114844 | PULMONARY KAPOSIS SARCOMA//EXTRAPULMONARY PNEUMOCYSTOSIS//PNEUMOCYSTIS CARINII PNEUMONIA |
6 | 0.0000105644 | RIFABUTIN//KRM 1648//RIFALAZIL |
7 | 0.0000096197 | VACUOLAR MYELOPATHY//AIDS DEMENTIA COMPLEX//CEREBRAL TOXOPLASMOSIS |
8 | 0.0000087144 | FLUORESCENT FOCUS ASSAY//FUYOU BRANCH//GLOBAL NEUROL PROGRAM |
9 | 0.0000083307 | TOXOPLASMA GONDII//TOXOPLASMA//SAG1 |
10 | 0.0000082354 | PENTAMIDINE//DIAMIDINES//AROMATIC DIAMIDINES |